Karam PE, Daher RT, Moller LB, Mikati MAExperience with hyperphenylalaninemia in a developing country: unusual clinical manifestations and a novel gene mutation. J Child Neurol. 2010. [Epub ahead of print: 10.1177/0883073810375116.]
2.
Ibarra-González I., Fernández-Lainez C., Belmont-Martínez L., Vela-Amieva M.Increased mortality and disability in a cohort of Mexican children with maple syrup urine disease. Gac Med Mex. 2007;143:197-201.
3.
Camfield CS, Joseph M., Hurley T., Campbell K., Sanderson S., Camfield PROptimal management of phenylketonuria: a centralized expert team is more successful than a decentralized model of care. J Pediatr . 2004;145:53-57.
